Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs
about
The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytesThe IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responsesAn autoinflammatory disease with deficiency of the interleukin-1-receptor antagonistIL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expressionInterleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activityOpposing activities of two novel members of the IL-1 ligand family regulate skin inflammationRegulatory Role of IL-1R8 in Immunity and DiseaseThe IL-1 cytokine family and its role in inflammation and fibrosis in the lungInterleukin-1 Family Cytokines in Liver DiseasesDeconstructing innate immune signaling in myelodysplastic syndromesCytokines in psoriasisTranscriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defenseGenome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotypeIL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cellsPsoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalkMutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis.Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birthAllelic variants of IL1R1 gene associate with severe hand osteoarthritis.An autoinflammatory disease due to homozygous deletion of the IL1RN locus.Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis.Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering DiseasesFunctional microarray analysis suggests repressed cell-cell signaling and cell survival-related modules inhibit progression of head and neck squamous cell carcinomaInterleukin-36β provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responsesA central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1Protein painting reveals solvent-excluded drug targets hidden within native protein-protein interfaces.Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.IL-1 family nomenclature.Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.IL-36α exerts pro-inflammatory effects in the lungs of miceCathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ.Differential transcriptome profile of peripheral white cells to identify biomarkers involved in oxaliplatin induced neuropathy.Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice.Role of IL-38 and its related cytokines in inflammationInterferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice.IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonistInterleukin (IL)-1β Is a Strong Inducer of IL-36γ Expression in Human Colonic Myofibroblasts.The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of IL-36γ.
P2860
Q21195661-DD02D7BD-7F80-4AFD-BCC6-60E3584F0810Q24303676-F5E881DA-1412-490C-BB54-8C64B8611470Q24606097-C2553160-1690-4D1C-ABC7-76CDF862CBA7Q24620194-22EEDF36-4ACB-4020-B4C3-0D38C57DC311Q24630062-7A5BCF0D-F91F-459A-A316-49208165A28BQ24676343-F297F3EE-35C3-4966-A652-E2B1CE81927DQ26752524-EB2D702C-ACD4-489C-B783-0890616E408BQ26752849-E8A47707-59FE-46C6-9239-3D56C527D5DBQ26778553-56DFAA1E-9489-40E5-9C03-C0739E95D46EQ26991974-676F2131-1513-4200-A909-819F19CA4A03Q28255491-46E29268-C97E-4631-BD7B-BD397381E2C9Q28306619-98E39825-9768-4B34-B3EB-E4E7891905E8Q28475905-7E8E0BAC-4755-45A5-A73F-8C36758A4D7CQ28513686-3DFF8831-CDD5-4505-988C-69F3D0D12C29Q28587108-C36BDCC8-4C3B-491F-B20E-F4BF9CC26264Q30420443-668C0F38-807F-4704-A853-245347C636EFQ30469652-C435B595-108A-405F-86D8-4F48DF3B169FQ33411968-30E37FA0-A8A8-4009-99E8-B7DB031978B9Q33547675-551CD8BA-73ED-495B-B4FE-FE5EC4F32489Q33577198-8FFD73E9-7B33-4117-A470-A43E0034CFC4Q33626536-B51CCF6E-8EE2-4BAE-AD2F-298691FB86D9Q33723794-D31DC7FF-7CBB-4CCA-B85A-675D51510866Q33751715-E35BFD95-59C8-4C6C-B4B2-154A39B889AFQ33762424-58373BB0-572A-445C-9177-DBEBAF0D98AFQ33871635-E9A47147-5460-44D8-AC52-0466F6CD029DQ33918535-417BBB8B-E6E9-409C-8607-CC7886EB52B1Q33921027-781B480D-9208-483B-9510-4E651BA8331BQ33942315-651B44C6-22F9-4030-8514-97245FE2CE40Q34129757-03584562-419D-4015-8962-82DB55E2C429Q34144622-A82DA90B-20CA-4496-834E-F0332E4E13EDQ34369278-B640EE00-869E-4503-8D8F-1BBD394EB4D6Q34430063-2775F305-8C7F-48FA-A0D7-169FFFC863B3Q34553191-C19535FC-541D-472E-B695-47A4FE9BB242Q34683946-261161C9-BDA1-4275-87D2-55F6F445AE56Q34768640-6FBB15E0-50FA-413F-9756-7318A94ACE5AQ35250392-9AB918E4-D43B-4EC6-85DA-B2849C49EBBFQ35752462-7A217A64-3C8C-4153-8014-DAC33D00AF53Q35779110-6376C9BE-149D-4BB0-BCAD-61A2664EC736Q35839978-95840A94-26F9-491D-AC36-7348D6AF34CFQ35888523-1F008BE2-3E91-4DB5-A7C9-5EB412558B66
P2860
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs
description
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2004
@ast
im April 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2 April 2004)
@en
vedecký článok (publikovaný 2004/04/02)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/04/02)
@nl
наукова стаття, опублікована у квітні 2004
@uk
name
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@ast
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@en
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@nl
type
label
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@ast
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@en
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@nl
prefLabel
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@ast
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@en
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@nl
P2093
P2860
P3181
P356
P1476
Interleukin (IL)-1F6, IL-1F8, ...... leading to NF-kappaB and MAPKs
@en
P2093
Blair R Renshaw
G Duke Virca
Jennifer E Towne
Kirsten E Garka
P2860
P304
P3181
P356
10.1074/JBC.M400117200
P407
P50
P577
2004-04-02T00:00:00Z